| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |